In conclusion, we find that VMAT2 expression has implications for the functioning catecholamine neurotransmission, its disruption in pathological conditions, stress and drug abuse, and its rescue via gene therapy strategies in neurodegenerative disorders like Parkinson's disease. This evidence concerns the gene SLC18A2 and Parkinson disease.